Insider Trading History of Lloyd Marcea Bland

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Lloyd Marcea Bland since 2012. The trader's CIK number is 1389208. At the time of the last reporting, Lloyd Marcea Bland was the SVP, Chief Administrative Offi of Poseida Therapeutics, Inc.. (stock ticker symbol PSTX). Also see all insider trading activities at Poseida Therapeutics, Inc..

Note that in the past Lloyd Marcea Bland also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Poseida Therapeutics, Inc. (PSTX) by Lloyd Marcea Bland

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 PSTX 10,000 $160,000 0 $0 0 $0

Yearly summary of insider trading at Amylin Pharmaceuticals Inc (AMLN) by Lloyd Marcea Bland

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 AMLN 0 $0 15,017 $253,546 0 $0


Insider trading activities at 2 companies by Lloyd Marcea Bland:

1. Poseida Therapeutics, Inc. (PSTX)

2. Amylin Pharmaceuticals Inc (AMLN)

Table 1. Insider trading of Poseida Therapeutics, Inc. (PSTX) by Lloyd Marcea Bland

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-07-14 PSTX Buy 10,000 16.00 160,000

Table 2. Insider trading of Amylin Pharmaceuticals Inc (AMLN) by Lloyd Marcea Bland

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-03-01 AMLN Sale 1,846 17.11 31,585
2012-02-23 AMLN Sale 7,518 17.03 128,031
2012-02-08 AMLN Sale 5,653 16.62 93,930

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lloyd Marcea Bland (SVP, Chief Administrative Offi of Poseida Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.